Inventory-Constrained Underwriters and Corporate Bond Offerings
The Review of Asset Pricing Studies · 18.08.2022 · 12 (3) · 639-666
DOI: 10.1093/rapstu/raab030 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Review of Asset Pricing Studies, online erschienen am 09.01.2022. Verfasst von Florian Nagler und 1 weiteren Autor:innen. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Fundação para a Ciência e a Tecnologia, Social Sciences DataLab, POR Lisboa.
Abstract (Originalsprache)
We empirically study how inventory constraints of underwriters affect corporate bond offerings. Using underwriter-insurer-level transaction data, we find that a more constrained underwriter is more likely to place a bond and increases the allocation in the primary market to an insurer with a stronger preexisting relationship. The same underwriter is also more likely to buy back part of an allocation from the same insurer within 6 to 12 months after an offering. Overall, by “parking” inventory to relationship investors in the primary market, underwriters mitigate the effect of their inventory constraints on firms’ bond financing costs. (JEL G12, G32)
Förderung
- Fundação para a Ciência e a Tecnologia
- Social Sciences DataLab
- POR Lisboa
- Social Sciences DataLab, Project 22209
- POR Norte [Social Sciences DataLab, Project 22209
Zitieren
APA
Nagler, F., & Ottonello, G. (2022). Inventory-Constrained Underwriters and Corporate Bond Offerings. The Review of Asset Pricing Studies, 12(3), 639-666. https://doi.org/10.1093/rapstu/raab030
Vancouver
Nagler F, Ottonello G. Inventory-Constrained Underwriters and Corporate Bond Offerings. The Review of Asset Pricing Studies. 2022;12(3):639-666. doi:10.1093/rapstu/raab030
BibTeX
@article{Nagler2022,
author = {Nagler, Florian and Ottonello, Giorgio},
title = {Inventory-Constrained Underwriters and Corporate Bond Offerings},
journal = {The Review of Asset Pricing Studies},
year = {2022},
volume = {12},
number = {3},
pages = {639--666},
doi = {10.1093/rapstu/raab030}
}
EUVIMED